C Thauvin-Eliopoulos
- Clinical Biochemistry top 1%
- Bacterial Identification and Susceptibility Testing 6
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria 4
- Infectious Diseases top 5%
- Antimicrobial Resistance in Staphylococcus 13
- Pharmacology top 10%
- Antibiotics Pharmacokinetics and Efficacy 8
-
- Infective Endocarditis Diagnosis and Management 7
- Urinary Tract Infections Management 1
-
- Bacterial biofilms and quorum sensing 3
-
- Bacterial Genetics and Biotechnology 2
- Co-authors
- George M. EliopoulosRobert C. MoelleringGeorge SakoulasJeff AlderChristine WennerstenHoward S. GoldR C MoelleringM. Tripodi
- Journals
- Clinical Infectious Diseases (1 paper)The Journal of Infectious Diseases (1 paper)Antimicrobial Agents and Chemotherapy (12 papers)
- Partner nations
- United StatesIsraelFrance
In The Last Decade
C Thauvin-Eliopoulos
17 papers receiving 632 citations
Peers
Comparison fields: 5 of 57
- Clinical Biochemistry 275
- Molecular Medicine 171
- Infectious Diseases 464
- Applied Microbiology and Biotechnology 41
- Pharmacology 149
Countries citing papers authored by C Thauvin-Eliopoulos
This map shows the geographic impact of C Thauvin-Eliopoulos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Thauvin-Eliopoulos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Thauvin-Eliopoulos more than expected).
Fields of papers citing papers by C Thauvin-Eliopoulos
This network shows the impact of papers produced by C Thauvin-Eliopoulos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Thauvin-Eliopoulos. The network helps show where C Thauvin-Eliopoulos may publish in the future.
Co-authorship network
The 25 scholars most cited alongside C Thauvin-Eliopoulos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 31 | |
| 2 | 2006 | 209 | |
| 3 | 2001 | 10 | |
| 4 | 2000 | 10 | |
| 5 | 2000 | 65 | |
| 6 | 1999 | 39 | |
| 7 | 1999 | 15 | |
| 8 | 1997 | 63 | |
| 9 | 1994 | 10 | |
| 10 | 1993 | 4 | |
| 11 | 1993 | 78 | |
| 12 | 1993 | 16 | |
| 13 | 1992 | 13 | |
| 14 | 1990 | 1 | |
| 15 | 1990 | 22 | |
| 16 | 1990 | 32 | |
| 17 | 1990 | 35 |
About C Thauvin-Eliopoulos
C Thauvin-Eliopoulos is a scholar working on Clinical Biochemistry, Molecular Medicine and Infectious Diseases, having authored 17 papers that have together received 653 indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (13 papers), Antibiotics Pharmacokinetics and Efficacy (8 papers), Infective Endocarditis Diagnosis and Management (7 papers), Bacterial Identification and Susceptibility Testing (6 papers), Antibiotic Resistance in Bacteria (4 papers), Bacterial biofilms and quorum sensing (3 papers), Bacterial Genetics and Biotechnology (2 papers) and Urinary Tract Infections Management (1 paper). The work is most often cited by research in Clinical Biochemistry (275 citations), Molecular Medicine (171 citations) and Infectious Diseases (464 citations). C Thauvin-Eliopoulos has collaborated with scholars based in United States, Israel and France. Frequent co-authors include George M. Eliopoulos, Robert C. Moellering, George Sakoulas, Jeff Alder, Christine Wennersten, Howard S. Gold, R C Moellering, M. Tripodi, Maria Souli and Emilia Cercenado. Their work appears in journals such as Clinical Infectious Diseases, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.